Safety And Immunogenicity Of The Adjunct Therapeutic Vaccine Id93 + Gla-Se In Adults Who Have Completed Treatment For Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2a Trial (Vol 9, Pg 373, 2021)

LANCET RESPIRATORY MEDICINE(2021)

引用 24|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要